Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care
RMD Open · 2025
DOI: 10.1136/rmdopen-2025-005705 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift RMD Open, 2025. Verfasst von Louise Majormoen Nielung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen Center for Arthritis Research, Glostrup, Denmark. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Arthritis, Psoriatic, Uveitis, Nail Diseases. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Danish Rheumatism Association.
Abstract (Originalsprache)
Background
In routine care, Danish patients with psoriatic arthritis are monitored in the DANBIO registry. In March 2022, patient-reported outcome measures (PROMs) on selected non-musculoskeletal manifestations (NMM) were implemented.
Aim
To validate PROMs for current dactylitis, skin and nail psoriasis, and recent uveitis in patients with psoriatic arthritis.
Methods
Adaptive cross-sectional study. Patients in the rheumatologic clinic answered PROMs with ‘yes’/‘no’/‘do not know’ and assessed the extent of skin psoriasis and number of dactylitis-affected digits in DANBIO. PROM entries were compared with the physician’s assessments (physical examination, review of patient file), with the physician being the gold standard. With 134 patients included, 20% had incorrectly reported dactylitis; therefore, a dactylitis photo was added to the PROM. Sensitivity, specificity, positive and negative predictive values, accuracy and Cohen’s kappa were calculated. Level of agreement for dactylitis count was explored by Bland-Altman plot. From patient 200, the physician was blinded to PROs.
Results
We included 300 patients (51% female, median age=55 years), with a median disease duration of 8 years, where 43% received biologic treatment. According to the physician’s assessment, 41 (14%) patients had current dactylitis, 164 (55%) psoriasis, 163 (54%) nail psoriasis and 3 (1%) recent uveitis. For the dactylitis PROM, the sensitivity/specificity/Cohen’s kappa was 0.89/0.81/0.57, psoriasis 1.0/0.94/0.95, nail psoriasis 0.76/0.94/0.66 and uveitis 1.00/0.99/0.59. Agreement on psoriasis extent was 90%. Patient-reported dactylitis count was on average 1.0 unit higher than physician-reported but decreased to 0.7 after adding the dactylitis photo. Results were similar irrespective of blinding.
Conclusion
Patients reliably self-report dactylitis, psoriasis, and uveitis and the PROMs are valuable for monitoring NMMs in routine care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen Center for Arthritis Research, Glostrup, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Rheumatology and Clinical Medicine, Aalborg Universitet, Aalborg, Denmark.
- Department of Dermatology and Allergy, Copenhagen University Hospital Gentofte, Hellerup, Denmark.
- Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen Center for Arthritis Research, Glostrup, Denmark glintborg@dadlnet.dk.
ORCID-Profile: Louise Majormoen Nielung, Merete Lund Hetland, Bente Glintborg
Förderung
- The Danish Rheumatism Association
Zitieren
APA
Nielung, L. M., Dreyer, L., Skov, L., Hetland, M. L., & Glintborg, B. (2025). Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care. RMD Open. https://doi.org/10.1136/rmdopen-2025-005705
Vancouver
Nielung LM, Dreyer L, Skov L, Hetland ML, Glintborg B. Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care. RMD Open. 2025. doi:10.1136/rmdopen-2025-005705
BibTeX
@article{Nielung2025,
author = {Nielung, Louise Majormoen and Dreyer, Lene and Skov, Lone and Hetland, Merete Lund and Glintborg, Bente},
title = {Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care},
journal = {RMD Open},
year = {2025},
doi = {10.1136/rmdopen-2025-005705}
}
EUVIMED